EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
EQHA.WS was delisted on the 25th of November, 2022.
47 hedge funds and large institutions have $7.49M invested in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
34% more capital invested
Capital invested by funds: $5.57M → $7.49M (+$1.92M)
9% more funds holding
Funds holding: 43 → 47 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IG
Inherent Group
New York
|
+$159K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$108K |
| 3 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
+$95.2K |
| 4 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$86.4K |
| 5 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$63.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$97K |
| 2 |
LA
Linden Advisors
New York
|
-$70K |
| 3 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$61.9K |
| 4 |
CP
Centerbridge Partners
New York
|
-$1 |
EQHA.WS Hedge Fund Activity: Q3 2021 in Review
47 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) for Q3 2021, worth a combined $7.49M — up 34% from $5.57M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new EQHA.WS positions and 3 closed out — a net gain of 4 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was Inherent Group, opening a new position worth an estimated $159K. The largest seller was Ionic Capital Management, exiting entirely with an estimated $97K sold.
- 47 institutional investors held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) as of Q3 2021, up from 43 in Q2 2021.
- Funds reported $7.49M of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q3 2021, up 34% quarter-over-quarter.
- 7 funds opened new EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q3 2021 and 3 closed out, a net change of +4 holders.
- The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q3 2021 was Inherent Group, an estimated $159K added.
- The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q3 2021 was Ionic Capital Management, an estimated $97K sold.
Based on aggregated 13F filings for Q3 2021.